A population genomics overview of the neuronal nitric oxide synthase (nNOS) gene and its relationship to migraine susceptibility

Cellular and Molecular Biology

Volumn 51, Issue 3, 2005, Pages 285-292

  Johnson, M P ^a   Lea, R A ^a,b   Colson, N J ^a   Macmillan, J C ^a   Griffiths, L R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

Association; Haplotype; Linkage disequilibrium; Migraine; nNOS

Indexed keywords

MICROSATELLITE DNA; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; AUTONOMIC INNERVATION; BRAIN BLOOD VESSEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA CONFORMATION; GENE ACTIVITY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE STRUCTURE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; MIGRAINE AURA; NEUROTRANSMISSION; NOCICEPTION; PERIPHERAL NERVOUS SYSTEM; POPULATION RESEARCH; PROMOTER REGION; SMOOTH MUSCLE CONTRACTILITY;

3' FLANKING REGION; 5' FLANKING REGION; ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; DNA, Z-FORM; EXONS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; ISOENZYMES; LINKAGE DISEQUILIBRIUM; MALE; MICROSATELLITE REPEATS; MIGRAINE DISORDERS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; PROMOTER REGIONS (GENETICS);

EID: 30744460901     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Boissel, J.P., Schwarz, P.M. and Forstermann, U., Neuronal-type NO synthase: transcript diversity and expressional regulation. Nitric Oxide 1998, 2: 337-349.
2. Boucher, C.A., King, S.K., Carey, N., Krahe, R., Winchester, C.L., Rahman, S., Creavin, T., Meghji, P., Bailey, M.E., Chartier, F.L., Brown, S.D., Siciliano, M.J. and Johnson, K.J., A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum. Mol. Genet. 1995, 4: 1919-1925.
3. Bruhwyler, J., Chleide, E., Liegeois, J.F. and Carreer, F., Nitric oxide: a new messenger in the brain. Neurosci. Biobehav. Rev. 1993, 17: 373-384.
4. Bult, H., Boeckxstaens, G.E., Pelckmans, P.A., Jordaens, F.H., Van Maercke, Y.M. and Herman, A.G., Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 1990, 345: 346-347.
5. Chung, E., Curtis, D., Chen, G., Marsden, P.A., Twells, R., Xu, W. and Gardiner, M., Genetic evidence for the neuronal nitric oxide synthase gene (NOS1) as a susceptibility locus for infantile pyloric stenosis. Am. J. Hum. Genet. 1996, 58: 363-370.
6. Colson, N.J., Lea, R.A., Quinlan, S., MacMillan, J. and Griffiths, L.R., The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 2004, 5: 129-133.
7. Comings, D.E., Polygenic inheritance and micro/minisatellites. Mol. Psychiatry 1998, 3: 21-31.
8. Dai, K.Z., Harbo, H.F., Celius, E.G., Oturai, A., Sorensen, P.S., Ryder, L.P., Datta, P., Svejgaard, A., Hillert, J., Fredrikson, S., Sandberg-Wollheim, M., Laaksonen, M., Myhr, K.M., Nyland, H., Vartdal, F. and Spurkland, A., The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun. 2001, 2: 263-268.
9. Dempster, A.P., Laird, N.M. and Rubin, D.B., Maximum likelihood from incomplete data via the EM algorithm. R Stat. Soc. Ser. B 1977, 39: 1-38.
10. Forstermann, U., Boissel, J.P. and Kleinert, H., Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 1998, 12: 773-790.
11. Grasemann, H., Drazen, J.M., Deykin, A., Israel, E., De Sanctis, G.T., Pillari, A. and Yandava, C.H., Simple tandem repeat polymorphisms in the neuronal nitric oxide synthase gene in different ethnic populations. Hum. Hered. 1999, 49: 139-141.
12. Grasemann, H., Yandava, C.N., Storm van's Gravesande, K., Deykin, A., Pillari, A., Ma, J., Sonna, L.A., Lilly C., Stampfer, M.J., Israel, E., Silverman, E.K. and Drazen, J.M., A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. Biochem. Biophys. Res. Commun. 2000, 272: 391-394.
13. Griffiths, L.R., Nyholt, D.R., Curtain, R.P., Goadsby P.J. and Brimage, P.J., Migraine association and linkage studies of an endothelial nitric oxide synthase (NOS3) gene polymorphism. Neurology 1997, 49: 614-617.
14. Hall, A.V., Antoniou, H., Wang, Y., Cheung, A.H., Arbus, A.M., Olson, S.L., Lu, W.C., Kau, C.L. and Marsden, P.A., Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J. Biol. Chem. 1994, 269: 33082-33090.
15. Headache Classification Committee of the International Headache Society, Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8(Suppl. 7): 1-96.
16. Huttley, G.A., Smith, M.W., Carrington, M. and O'Brien, S.J., A scan for linkage disequilibrium across the human genome. Genetics 1999, 152: 1711-1722.
17. Iversen, H.K., Olesen, J. and Tfelt-Hansen, P., Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 1989, 38: 17-24.
18. Lance, J.W. and Goadsby, P.J., Mechansim and Management of Headache, Butterworth-Heinemann, Oxford, England, 1998, pp. 40-44.
19. Lassen, L.H., Ashina, M., Christiansen, I., Ulrich, V., Grover, R., Donaldson, J. and Olesen, J., Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 1998, 18: 27-32.
20. Lassen, L.H., Ashina, M., Christiansen, I., Ulrich, V. and Olesen, J., Nitric oxide synthase inhibition in migraine. Lancet 1997, 349: 401-402.
21. Lea, R.A., Curtain, R.P., Shepherd, A.G., Brimage, P.J. and Griffiths, L.R., No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. Am. J. Med. Genet. 2001, 105: 110-113.
22. Lewontin, R.C., The interaction of selection and linkage I. General considerations; heterotic models. Genetics 1964, 49: 49-67.
23. Liou, Y.J., Hong, C.J., Liu, H.C., Liu, T.Y., Chen, I.C. and Tsai, S.J., No association between the neuronal nitric oxide synthase gene polymorphism and alzheimer disease. Am. J. Med. Genet. 2002, 114B: 687-688.
24. Liou, Y.J., Tsai, S.J. and Liao, D.L., Association analysis for the CA repeat polymorphism of the neuronal oxide synthase (NOS1) gene and schizophrenia. Schizophr. Res. 2003, 65: 57-59.
25. Lo, H.S., Hogan, E.L. and Soong, B.W., 5′-flanking region polymorphism of the neuronal nitric oxide synthase gene with Parkinson's disease in Taiwan. J. Neurol. Sci. 2002, 194: 11-13.
26. Miller, S.A., Dykes, D.D. and Polesky H.F., A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 1988, 16: 1215.
27. Modin, H., Dai, Y., Masterman, T., Svejgaard, A., Sorensen, P.S., Oturai, A., Ryder, L.P., Spurkland, A., Vartdal, F., Laaksonen, M., Sandberg-Wollheim, M., Myhr, K.M., Nyland, H. and Hillert, J., No linkage or association of the nitric oxide synthase genes to multiple sclerosis. J. Neuroimmunol. 2001, 119: 95-100.
28. Nadaud, S. and Soubrier, F., Molecular biology and molecular genetics of nitric oxide synthase genes. Clin. Exp. Hypertens. 1996, 18: 113-143.
29. Naylor, L.H. and Clark, E.M., d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription. Nucl. Acids Res. 1990, 18: 1595-1601.
30. Nozaki, K., Moskowitz, M.A., Maynard, K.I., Koketsu, N., Dawson, T.M., Bredt, D.S. and Snyder, S.H., Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries. J. Cereb. Blood Flow Metabol. 1993, 13: 70-79.
31. Oh, D.B., Kim, Y.G. and Rich, A., Z-DNA-binding proteins can act as potent effectors of gene expression in vivo. Proc. Natl. Acad. Sci. USA 2002, 99: 16666-16671.
32. Olesen, J., Iversen, H.K. and Thomsen, L.L., Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 1993, 4: 1027-1030.
33. Olesen, J., Thomsen, L.L., Lassen, L.H. and Olesen, I.J., The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 1995, 15: 94-100.
34. Peunova, N. and Enikolopov, G., Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature 1993, 364: 450-453.
35. Rothenburg, S., Koch-Nolte, F., Rich, A. and Haag, F., A polymorphic dinucleotide repeat in the rat nucleolin gene forms Z-DNA and inhibits promoter activity. Proc. Natl. Acad. Sci. USA 2001, 98: 8985-8990.
36. Schneider, S., Roessli, D. and Excoffier, L., Arlequin ver. 2.000: A Software for Population Genetics Data Analysis, 2000, http://anthro.unige.ch/ arlequin
37. Schroth, G.P., Chou, P.J. and Ho, P.S., Mapping Z-DNA in the human genome. J. Biol. Chem. 1992, 267: 11846-11855.
38. Sham, P.C. and Curtis, D., Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 1995, 59(Pt 1): 97-105.
39. Sjostrand, C., Modin, H., Masterman, T., Ekbom, K., Waldenlind, E. and Hillert, J., Analysis of nitric oxide synthase genes in cluster headache. Cephalalgia 2002, 22: 758-764.
40. Slatkin, M., Linkage disequilibrium in growing and stable populations. Genetics 1994, 137: 331-336.
41. Tajouri, L., Ferreira, L., Ovcaric, M., Curtain, R., Lea, R., Csurhes, P., Pender, M.P. and Griffiths, L.R., Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism in a multiple sclerosis population. J. Neurol. Sci. 2004, 218: 25-28.
42. Takahashi, Y., Nakayama, T., Soma, M., Uwabo, J., Izumi, Y. and Kanmatsuse, K., Association analysis of TG repeat polymorphism of the neuronal nitric oxide synthase gene with essential hypertension. Clin. Genet. 1997, 52: 83-85.
43. Terwilliger, J.D. and Ott, J., Handbook of Human Genetic Linkage, The John Hopkins University Press, Baltimore, Maryland, USA, 1994, pp. 188-198.
44. Texereau, J., Marullo, S., Hubert, D., Coste, J., Dusser, D.J., Dall'Ava-Santucci, J. and Dinh-Xuan, A.T., Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis. Thorax 2004, 59: 156-158.
45. Thomsen, L.L. and Olesen, J., Nitric oxide theory of migraine. Clin. Neurosci. 1998, 5: 28-33.
46. Wang, Y., Newton, D.C. and Marsden, P.A., Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit. Rev. Neurobiol. 1999, 13: 21-43.
47. Wang, Y., Newton, D.C., Robb, G.B., Kau, C.L., Miller, T.L., Cheung, A.H., Hall, A.V., VanDamme, S., Wilcox, J.N. and Marsden, P.A., RNA diversity has profound effects on the translation of neuronal nitric oxide synthase. Proc. Natl. Acad. Sci. USA 1999, 96: 12150-12155.
48. World Health Organization, The World Health Report 2001: Mental Health: New Understanding, New Hope, World Health Organization, Geneva, 2001, pp. 19-46.
49. Xie, X. and Ott, J., Testing linkage disequilibrium between a disease gene and marker loci. Am. J. Hum. Genet. 1993, 53: Abstract 1107.
50. Xu, W., Gorman, P., Sheer, D., Bates, G., Kishimoto, J., Lizhi, L. and Emson, P., Regional localization of the gene coding for human brain nitric oxide synthase (NOS1) to 12q24.2→24.31 by fluorescent in situ hybridization. Cytogenet. Cell Genet. 1993, 64: 62-63.
51. Xu, X., Peng, M. and Fang, Z., The direction of microsatellite mutations is dependent upon allele length. Nat. Genet. 2000, 24: 396-399.
52. Zhang, T., Haws, P. and Wu, Q., Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. Genome Res. 2004, 14: 79-89.
53. Zhao, J.H., 2LD - Two-Locus Linkage Disequilibrium (LD) calculator, 2002, http://www.iop.kcl.ac.uk/IoP/Departments/PsychMed/GEpiBSt/software.shtml